decisionhealth Newsletters, Part B News - 2015 Issue 8 (August)
Top incorrect units-of-service drugs had low denials through OIG investigation
Subscribe or sign in to view the full article.
Article Overview
This Find-A-Code article summarizes an OIG review of Part B drug overpayments and discusses how denial trends looked for the drugs most often associated with incorrect units of service. It is relevant to Medicare billing, compliance, and denial management audiences that monitor drug claims, contractor review activity, and HCPCS-related payment issues.
Why This Topic Matters
The piece helps readers understand why certain drug claims drew OIG attention even though denial rates remained relatively low during the investigation period. It is useful for identifying compliance risk areas, reviewing contractor scrutiny patterns, and tracking changes in drug billing oversight.
What You Will Learn
- What the OIG investigation examined in relation to Part B drug overpayments
- Which general claim-payment and denial trends the article compares
- How contractor review activity is discussed in relation to selected drug billing
- Why the article notes later data beyond the original investigation period
Who Should Read This
- Medical coders
- Billing professionals
- Compliance officers
- Revenue cycle staff
- Hospital outpatient billing teams
- Medicare claims auditors
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com